Literature DB >> 21747027

Oculomotor dysfunction in amyotrophic lateral sclerosis: a comprehensive review.

Rakesh Sharma1, Stephen Hicks, Claire M Berna, Christopher Kennard, Kevin Talbot, Martin R Turner.   

Abstract

Although traditionally regarded as spared, a range of oculomotor dysfunction has been recorded in patients with amyotrophic lateral sclerosis (ALS). Most frequent is ophthalmoparesis, particularly in patients with prolonged survival; however, pursuit, nystagmus, and saccadic impairments have also been reported. The apparent resistance to pathologic involvement of oculomotor (and sphincter) control pathways in most patients with ALS has prompted comparative study to establish the key pathways that underlie motor neuronal vulnerability, with the hope of generating novel therapeutic strategies. Developments in the assessment of oculomotor function, including portable eye-tracking devices, have revealed more subtle impairments in ALS in relation to phenotype, which can now be better understood through parallel elucidation of the normal cerebral oculomotor control network. Given the clinicopathologic overlap between ALS and some types of frontotemporal dementia, the study of oculomotor function has particular value in probing the variable but consistent cognitive impairment seen in ALS and that reflects frontotemporal extramotor cerebral abnormalities. By transcending the requirement to write or speak, loss of which precludes standard neuropsychological testing in some patients with advanced ALS, cognitive tests performed using only oculomotor functions offer additional potential, allowing the study of patients much later in their disease course. The study of oculomotor dysfunction holds significant promise as an additional source of much needed prognostic, monitoring, and mechanistic biomarkers for ALS.

Entities:  

Mesh:

Year:  2011        PMID: 21747027     DOI: 10.1001/archneurol.2011.130

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  40 in total

1.  Eye-tracking controlled cognitive function tests in patients with amyotrophic lateral sclerosis: a controlled proof-of-principle study.

Authors:  Jürgen Keller; Martin Gorges; Hannah T Horn; Helena E A Aho-Özhan; Elmar H Pinkhardt; Ingo Uttner; Jan Kassubek; Albert C Ludolph; Dorothée Lulé
Journal:  J Neurol       Date:  2015-06-05       Impact factor: 4.849

2.  An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study.

Authors:  Timothy M Miller; Alan Pestronk; William David; Jeffrey Rothstein; Ericka Simpson; Stanley H Appel; Patricia L Andres; Katy Mahoney; Peggy Allred; Katie Alexander; Lyle W Ostrow; David Schoenfeld; Eric A Macklin; Daniel A Norris; Georgios Manousakis; Matthew Crisp; Richard Smith; C Frank Bennett; Kathie M Bishop; Merit E Cudkowicz
Journal:  Lancet Neurol       Date:  2013-03-29       Impact factor: 44.182

3.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

4.  A practical, intuitive brain-computer interface for communicating 'yes' or 'no' by listening.

Authors:  N Jeremy Hill; Erin Ricci; Sameah Haider; Lynn M McCane; Susan Heckman; Jonathan R Wolpaw; Theresa M Vaughan
Journal:  J Neural Eng       Date:  2014-05-19       Impact factor: 5.379

5.  Eye-Tracking Control to Assess Cognitive Functions in Patients with Amyotrophic Lateral Sclerosis.

Authors:  Jürgen Keller; Martin Gorges; Helena E A Aho-Özhan; Ingo Uttner; Erich Schneider; Jan Kassubek; Elmar H Pinkhardt; Albert C Ludolph; Dorothée Lulé
Journal:  J Vis Exp       Date:  2016-10-13       Impact factor: 1.355

6.  Detection of third and sixth cranial nerve palsies with a novel method for eye tracking while watching a short film clip.

Authors:  Uzma Samadani; Sameer Farooq; Robert Ritlop; Floyd Warren; Marleen Reyes; Elizabeth Lamm; Anastasia Alex; Elena Nehrbass; Radek Kolecki; Michael Jureller; Julia Schneider; Agnes Chen; Chen Shi; Neil Mendhiratta; Jason H Huang; Meng Qian; Roy Kwak; Artem Mikheev; Henry Rusinek; Ajax George; Robert Fergus; Douglas Kondziolka; Paul P Huang; R Theodore Smith
Journal:  J Neurosurg       Date:  2014-12-12       Impact factor: 5.115

7.  ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.

Authors:  Leo McCluskey; Shannon Vandriel; Lauren Elman; Vivianna M Van Deerlin; John Powers; Ashley Boller; Elisabeth McCarty Wood; John Woo; Corey T McMillan; Katya Rascovsky; Murray Grossman
Journal:  J Neurol Sci       Date:  2014-07-18       Impact factor: 3.181

8.  Retinal involvement in amyotrophic lateral sclerosis: a study with optical coherence tomography and diffusion tensor imaging.

Authors:  Annemarie Hübers; Hans Peter Müller; Jens Dreyhaupt; Kathrin Böhm; Florian Lauda; Hayrettin Tumani; Jan Kassubek; Albert C Ludolph; Elmar H Pinkhardt
Journal:  J Neural Transm (Vienna)       Date:  2015-11-18       Impact factor: 3.575

9.  Eye-tracking in amyotrophic lateral sclerosis: A longitudinal study of saccadic and cognitive tasks.

Authors:  Malcolm Proudfoot; Ricarda A L Menke; Rakesh Sharma; Claire M Berna; Stephen L Hicks; Christopher Kennard; Kevin Talbot; Martin R Turner
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2015-08-27       Impact factor: 4.092

Review 10.  Mimics and chameleons in motor neurone disease.

Authors:  Martin R Turner; Kevin Talbot
Journal:  Pract Neurol       Date:  2013-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.